Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results
Document Details
Form
Filing Date
Jun 24, 2019
Document Date
Jun 20, 2019
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/
Filer
McGeorge Anne